how do glp-1 inhibitors work and the kidney: from physiology to pharmacology and outcomes in diabetes Glucagon-like peptide-1 - Wikipedia
Description
A little less fizz and drama for 24 hours
Molecules 28 , 2982 (2023)
Implications for pharma companies: Pharmas entry into the trillion-dollar club is largely driven by success in a treatment category (obesity) poised to reshape consumer health and wellness, given the massive demand for better weight loss solutions
Mol Metab 30:72130 Kabahizi A et al (2022) Glucagon-like peptide-1 (GLP-1) signalling in the brain: from neural circuits and metabolism to therapeutics
In a study of more than 3,000 people using semaglutide 2.4 mg weekly for weight loss, over 40% reported nausea
Because these medications suppress appetite and slow digestion, protein and overall nutrient intake are even more important
